India Globalization Capital Inc
F:IGS1
India Globalization Capital Inc
Research & Development
India Globalization Capital Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
India Globalization Capital Inc
F:IGS1
|
Research & Development
-$4.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
W W Grainger Inc
NYSE:GWW
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
United Rentals Inc
NYSE:URI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fastenal Co
NASDAQ:FAST
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
WW Grainger Inc
XMUN:GWW
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ferguson Enterprises Inc
NYSE:FERG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
India Globalization Capital Inc
Glance View
India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The company is headquartered in Potomac, Maryland and currently employs 50 full-time employees. The company went IPO on 2006-04-13. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment involves the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, among others, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment involves execution of construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer.
See Also
What is India Globalization Capital Inc's Research & Development?
Research & Development
-4.2m
USD
Based on the financial report for Sep 30, 2025, India Globalization Capital Inc's Research & Development amounts to -4.2m USD.
What is India Globalization Capital Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-34%
Over the last year, the Research & Development growth was -18%. The average annual Research & Development growth rates for India Globalization Capital Inc have been -4% over the past three years , -34% over the past five years .
